These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15921250)

  • 1. [Chemoprevention of prostate cancer].
    Xie LP; Qin J
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):243-6. PubMed ID: 15921250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of prostate cancer.
    Klein EA
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):1-10. PubMed ID: 15780904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of prostate cancer.
    Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer chemoprevention: a summary of the current evidence.
    Bonovas S; Tsantes A; Drosos T; Sitaras NM
    Anticancer Res; 2008; 28(3B):1857-66. PubMed ID: 18630472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer chemoprevention: models, limitations and potential (Review).
    Gupta S
    Int J Oncol; 2004 Oct; 25(4):1133-48. PubMed ID: 15375566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary agents in the chemoprevention of prostate cancer.
    Shukla S; Gupta S
    Nutr Cancer; 2005; 53(1):18-32. PubMed ID: 16351503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future status of prostate cancer chemoprevention.
    Fujimoto N; Nomura M; Matsumoto T
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention research: implications for primary care practice.
    Denicoff AM; Padberg RM
    Lippincotts Prim Care Pract; 2000; 4(4):410-6. PubMed ID: 11261117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer chemoprevention by green tea.
    Gupta S; Ahmad N; Mukhtar H
    Semin Urol Oncol; 1999 May; 17(2):70-6. PubMed ID: 10332919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
    Siddiqui IA; Afaq F; Adhami VM; Mukhtar H
    Chem Biol Interact; 2008 Jan; 171(2):122-32. PubMed ID: 17403520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of prostate cancer through dietary agents: progress and promise.
    Syed DN; Khan N; Afaq F; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2193-203. PubMed ID: 18006906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is active surveillance the appropriate treatment for prostate cancer?
    Albertsen PC
    Acta Oncol; 2011 Jun; 50 Suppl 1():120-6. PubMed ID: 21604952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of prostate cancer, chemoprevention and active surveillance.
    Bratt O; Schumacher MC
    Acta Oncol; 2011 Jun; 50 Suppl 1():116-9. PubMed ID: 21604951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.